Endocare and Galil Medical to Merge
Only months after Healthtronics withdrew its offer to acquire Endocare for $2.28 per share, Endocare and privately held Galil Medical have agreed to merge. The […]
news2
Abiomed: Record Revenue Driven by Impella
In June, Abiomed got the green light from the FDA to market its Impella 2.5 CAD, a minimally invasive ventricular assist device. At the time, […]
[Video Interview] Richard Taney, President & CEO of Delcath Systems
One of the central problems in using chemotherapy to treat cancer is its harmful effect on organ health. Lower dosages of the drug are often […]
AngioDynamics Integrates Diomed’s EVLT
Having acquired onetime rival Diomed for a song, AngioDynamics has launched a new varicose vein therapy brand, VenaCure EVLT. The new brand combines AngioDynamics’ VenaCure […]
Symphony Medical Raises $10 Million
Symphony Medical, a privately-held company developing novel biocompatible polymer therapies to treat chronic heart failure and atrial fibrillation has raised $10 million in a Series […]
CryoLife: EPS Increases, Revenues Up 21%
Revenues at CryoLife rose 21% to $26.8 million in the third quarter of 2008. Net income was $3.6 million, or $0.13 per share, compared to […]
NxStage: Medisystems Business Disappoints
NxStage Medical may be losing steam. The maker of dialysis products reported third quarter revenues of $30.5 million, a slight decrease from the $31.6 million […]
Clarient: Q3 Revenues up 59%; Raises Guidance
Third quarter revenues at Clarient increased 59% to $19.0 million from the $11.9 million reported in Q3 2007. This marks the company’s 17th consecutive quarter […]
[Video Profile] Sherlock-NMD
When an athlete is injured, their career and value to the team are at risk. At all levels of athletics, including everyday fitness enthusiasts, the […]
Langer Sheds Orthotics Business to Cut the Fat
Only months after Langer sold its Bi-Op subsidiary for less than its purchase price, the company announced the sale of its custom orthotics business to […]